MRNA Icon

$MRNA

$MRNA

Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The companys respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses includ...

Stocks

Total Asset Value

$4,110,229

▼19.89%from 30d ago

Holders

14,584

▲+5.92%from 30d ago

Monthly Transfer Volume

$981.31M

▲+711.15%from 30d ago

Moderna

Return Target

Not supplied yet.

Asset Class

Stocks

Exposure

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The companys respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Liquidity

Not supplied yet.

Asset Manager

Asset manager details have not been supplied yet.

Management Team

Management team details have not been supplied yet.

Moderna Metrics

Legal Structure & Regulation

Type
Equity
ISIN
US60770K1079

Tokenized Public Stocks

10 Total

Transactions

All networks · changes vs. 30 days ago